News

Minerva Foods Achieves Record Free Cash Flow in Q3 2025

Minerva Foods Achieves Record Free Cash Flow in Q3 2025

Minerva Foods Reports Stellar Free Cash Flow Performance

Minerva Foods, a key player in the global food industry, has announced remarkable financial results for the recent third quarter. The free cash flow for this period reached an impressive R$2.5 billion, marking the highest level recorded by the company in any single quarter. This surge in free cash flow signals the firm's robust operational capabilities and strategic positioning in the market.

Financial Highlights and Operational Growth

During this quarter, the company saw a noteworthy decline in leverage, with the Net Debt/Adjusted EBITDA ratio falling to 2.5x—the lowest level since 2022. This positive trend indicates a strong financial health and effective management of debts. Notably, the net revenue for the third quarter reached R$15.5 billion, representing an extraordinary increase of 82.5% compared to the previous year, and a 11.5% rise from the earlier quarter.

Record-Breaking EBITDA Margins

EBITDA for the third quarter was reported at R$1.4 billion, again a new quarterly record for the company. This translates to an EBITDA margin of 8.9%, which is up by 70.8% year-on-year and shows improvement compared to the second quarter's performance. The adjusted EBITDA figure for the past year stands at R$4.7 billion, indicating the successful integration of new assets that have boosted profitability.

Strong Revenue and Export Growth

Consolidated gross revenue exceeded R$16.3 billion in the quarter, showcasing an increase of 80.1% compared to the same period last year, with exports accounting for a significant 61% of total revenue. Over the past year, the gross revenue surged to R$54.4 billion, underlining a 73.1% annual increase, with exports reaching 58%. This indicates that Minerva Foods is successfully broadening its international market reach.

Impact of Strategic Initiatives

The quarter also saw net income reach R$120 million, contributing to a year-to-date total net income of R$763.3 million. The integration of newly acquired assets was completed successfully, with sales volumes increasing by 10% and revenue rising by 11% compared to the previous quarter. Such strategic initiatives have fostered higher profitability and reduced costs, as shown by the SG&A-to-revenue ratio dropping to its lowest since early 2021.

Capital Structure and Repurchase Programs

In a continuing effort to strengthen its capital structure, Minerva Foods exercised 5,847,096 subscription bonuses from a capital increase, amounting to R$30.2 million. An additional R$969.3 million in subscription bonuses are anticipated by mid-2028 when exercised. Furthermore, the company reported a significant bond repurchase and cancellation amounting to USD 75.7 million, or R$402.6 million, linked to the 2031 bonds. To date, Minerva has successfully repurchased USD 384.8 million in external bonds, emphasizing its commitment to financial stability.

About Minerva Foods

Minerva Foods stands as the leading exporter of beef in South America, recognized globally for its high-quality products. The company operates under brands such as Pul, Estancia 92, and Cabaña Las Lilas. With a presence in over 100 countries and a workforce of more than 30,000 individuals across several industrial units, it demonstrates a robust operational capacity. The Minerva S.A. group consists of Minerva Energy, Minerva Biodiesel, Minerva Ingredients, Minerva Casings, Minerva Leather, and MyCarbon, further solidifying its diverse market presence.

Minerva Foods is dedicated to delivering premium food products, including beef and lamb, to a worldwide audience. Operating in regions like Brazil, Paraguay, Argentina, Uruguay, Colombia, Chile, and Australia, the group continues to expand its influence in the food sector, promising excellent quality and value to its customers.

Frequently Asked Questions

What was Minerva Foods' free cash flow in the third quarter?

The free cash flow reached an impressive R$2.5 billion during the third quarter.

How has net revenue changed for Minerva Foods?

Net revenue reached R$15.5 billion, marking an increase of 82.5% year-over-year.

What is the significance of the EBITDA reported?

Minerva Foods recorded an EBITDA of R$1.4 billion, setting another quarterly record with an 8.9% margin.

What impact did new asset integration have on the company?

New asset integration led to a 10% rise in sales volume and contributed to increased revenue.

Can you summarize Minerva Foods' operational reach?

Minerva Foods operates in over 100 countries and employs more than 30,000 staff, highlighting its global presence.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Spruce Point's Strong Sell Rating Casts Doubt on Construction Partners

Updated Category News Views 116

Spruce Point's Strong Sell Opinion on Construction Partners Inc Spruce Point Capital Management has recently issued a compelling report regarding Construction Partners Inc (NASDAQ: ROAD), a company recognized for its expertise in infrastructure and road construction. This report voices a strong sell recommendation, reflecting serious concerns over the company's current...

Continue Reading
Celebrating Excellence in Healthcare: Press Ganey's Honorees

Updated Category News Views 344

Celebrating the Executive Human Experience Award Winners Press Ganey, an industry leader dedicated to enhancing healthcare experiences, recently celebrated exceptional achievements in the field. During its annual conference, the Executive Human Experience Awards recognized extraordinary contributions from professionals and organizations that prioritize patient, consumer,...

Continue Reading
Commercial Vehicle Market Growth Driven by Technology Advancements

Updated Category News Views 122

Commercial Vehicle Market Growth and Projections The global commercial vehicle market is on an upward trajectory, with sales expected to reach 3.5 million units by 2025. The anticipated Year-over-Year (YoY) growth of 4.4% from 2024 highlights the increasing demand for medium and heavy commercial vehicles. This trend is being driven by several factors, including...

Continue Reading
Atos Receives Prestigious EcoVadis Platinum Medal Again

Updated Category News Views 195

Let’s not beat around the bush—Atos is doing something right in the sustainability game. They've bagged the EcoVadis Platinum Medal for five years running. Yep, that’s a serious flex in today’s corporate climate where ‘green’ isn’t just a buzzword; it’s almost an obligation if you want to stay relevant. The Metrics Behind Atos's Shine Scoring a...

Continue Reading
Power Metallic Mines Updates Shareholder Meeting Outcomes

Updated Category News Views 157

Power Metallic Mines Reports on AGSM Meeting Outcomes Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) expressed satisfaction with the voting outcomes from its Annual General and Special Meeting ("AGSM") that took place recently. The meeting gathered shareholders to discuss essential business items and elect members to the Board of...

Continue Reading